Depression and Inflammation in Women with Breast Cancer: Risk and Resilience Factors

By sjmartinez • May 14, 2025

Korecki JRT, Slavich GM, Ganz PA, Irwin MR, Cole S, Crespi CM, Bower JE. Depression and Inflammation in Women with Breast Cancer: Risk and Resilience Factors. Biopsychosoc Sci Med. 2025 May 9. doi: 10.1097/PSY.0000000000001398. Epub ahead of print. PMID: 40359350.

Tags: and Energy study, BMI, body mass index, breast cancer survivors, C-reactive protein, CBT-I, Center for Epidemiological Studies Depression Scale, CES-D, CI, cognitive behavioral therapy for insomnia, confidence interval, CRP, depression, Hematology/Oncology, IL-6, Inflammation, interleukin, Life Orientation Test-Revised, lifetime stressor exposure, LOT-R, PA, physical activity, Pittsburgh Sleep Quality Index, PSQI, Publications, Research on Inflammation, resilience, RISE, SD, standard deviation, Strain, Stress, Stress and Adversity Inventory, TNF-α, Tumor necrosis factor-α

Related Posts

Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma

Chan SL, Finn RS, Edeline J, Ogasawara S, Knox JJ, Daniele B, Ryoo BY, Merle P, Bouattour M, Lim HY, Chao Y, Yau T, Haber[...]

First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial

Sun JM, Chao Y, Kim SB, Rha SY, Evans TRJ, Strickland AH, Wainberg Z, Chau I, Pelles-Avraham S, Ajani J, Malhotra R, Liu Q, Li[...]

Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone-receptor-positive HER2-negative breast cancer: final overall survival analysis of the phase 3 TROPION-Breast01 study

Pistilli B, Jhaveri K, Im SA, Pernas S, De Laurentiis M, Wang S, Jañez NM, Borges G, Cescon DW, Hattori M, Lu YS, Hamilton E,[...]